Cargando…
Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication
Cardiomyocytes undergo cell division during the fetal period but do not divide after birth; thus, they grow into adult heart cells by enlarging their size. Therefore, heart failure occurs when a certain number of cardiomyocytes are lost owing to myocardial infarction, myocarditis, sarcoidosis, etc....
Autor principal: | Fukuda, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628313/ https://www.ncbi.nlm.nih.gov/pubmed/37941693 http://dx.doi.org/10.31662/jmaj.2023-0075 |
Ejemplares similares
-
Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
por: Kishino, Yoshikazu, et al.
Publicado: (2023) -
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021) -
Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies
por: Correia, Magda, et al.
Publicado: (2022) -
Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022) -
Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
por: Silver, Sophia E., et al.
Publicado: (2021)